Skip to main content
. Author manuscript; available in PMC: 2020 Sep 16.
Published in final edited form as: Gastrointest Endosc. 2018 Apr 27;88(3):413–426. doi: 10.1016/j.gie.2018.04.2352

Table 2:

Pros and Cons of Various Endoscopic Screening Methods

Endoscopic screening modalities Pros Cons PIVI criteria for Squamous Dysplasia Reached?
All modalities •Visualizes the mucosa • Uncomfortable if not done with sedation (which is frequently not available in resource poor areas)
• Requires operator training and experience
• Expensive equipment
Conventional white light endoscopy • Readily available in developed areas • Lacks sensitivity for precursor lesions • No
Chromoendoscopy • Inexpensive
• Improves sensitivity for precursor lesions/dysplasia
• Short learning curve
• Clarity of lesion borders
• Irritant/allergic reactions to iodine
• Lower specificity for precursor lesions (before biopsy diagnosis)
• Yes
Endoscopy with Narrow Band Imaging • Improves sensitivity and specificity for precursor lesions/dysplasia
• Does not require iodine
• Increased cost of equipment
• Longer learning curve
• Requires more operator expertise
• Yes
Transnasal endoscopy • No need for sedation
• Improves cost effectiveness
• Currently not standard of care, not widely available
• Lack of trained operators
• Cannot be combined with Lugol’s or NBI to detect precursor lesions.
• Not yet tested on precursor lesions
• Smaller biopsies
• No therapeutic capabilities
• Increased risk for patients with ENT pathology
• Yes (only if combined with FICE)
Endocytoscopy • Cellular level resolution may obviate need for some or all biopsies • A contact probe technology
• Small field of view
• Can only be used with other lesion localization technologies (Lugol’s or NBI)
• Increased cost of equipment
• Additional training needed
• Not yet tested on precursor lesions
• Yes
Microendoscopy • Inexpensive and portable
• Cellular level resolution may obviate need for some or all biopsies
• Can be portable and added to standard endoscope
• High sensitivity and specificity for dysplasia and early stage cancer.
• A contact probe technology
• Small field of view
• Can only be used with other lesion localization technologies (Lugol’s or NBI)
• Additional training needed
• Variable cost-effectiveness when compared to standard endoscopic screening techniques
• Yes